The FDA has approved the first GLP-1 pill for weight loss, clearing a tablet from Novo Nordisk

Core Viewpoint - Novo Nordisk plans to launch a new pill in the U.S. market shortly after the new year, with a cash price set at $149 per month for the initial dosage [1] Company Summary - The new pill will be available for purchase in the U.S. soon after the start of the new year [1] - The pricing strategy includes a cash price of $149 per month for the starting dose [1]